Anterogen.Co.,Ltd. (KOSDAQ:065660)
South Korea · Delayed Price · Currency is KRW 35,050
+900 (2.64%)
Dec 11, 2025, 3:30 PM KST
Anterogen.Co.,Ltd. Market Cap
Anterogen.Co.,Ltd. has a market cap or net worth of 341.71 billion as of December 11, 2025. Its market cap has increased by 141.83% in one year.
Market Cap
341.71B
Enterprise Value
297.62B
Revenue
7.32B
Ranking
n/a
PE Ratio
n/a
Stock Price
35,050.00
Market Cap Chart
Since February 15, 2016, Anterogen.Co.,Ltd.'s market cap has increased from 291.82B to 341.71B, an increase of 17.10%. That is a compound annual growth rate of 1.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 350.71B | 90.79% |
| Dec 30, 2024 | 183.83B | 10.53% |
| Dec 28, 2023 | 166.31B | 16.26% |
| Dec 29, 2022 | 143.05B | -76.39% |
| Dec 30, 2021 | 605.82B | 6.94% |
| Dec 30, 2020 | 566.53B | 52.66% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.84T |
| Celltrion | 40.98T |
| ALTEOGEN | 24.44T |
| SK Biopharmaceuticals | 10.58T |
| ABL Bio | 10.26T |
| Yuhan | 8.70T |
| LigaChem Biosciences | 6.67T |
| Peptron | 6.54T |